15687-41-9,MFCD00869256
Catalog No.:AA01E2BI

15687-41-9 | Oxyfedrine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
3 weeks  
$580.00   $406.00
- +
50mg
3 weeks  
$3,359.00   $2,351.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01E2BI
Chemical Name:
Oxyfedrine
CAS Number:
15687-41-9
Molecular Formula:
C19H23NO3
Molecular Weight:
313.3908
MDL Number:
MFCD00869256
SMILES:
COc1cccc(c1)C(=O)CCN[C@H]([C@@H](c1ccccc1)O)C
Properties
Computed Properties
 
Complexity:
355  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.4  

Literature

Title: Physiological changes induced by chromium stress in plants: an overview.

Journal: Protoplasma 20120701

Title: In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains.

Journal: Biological & pharmaceutical bulletin 20050401

Title: Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis.

Journal: Bulletin of experimental biology and medicine 20041001

Title: Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.

Journal: Bulletin of experimental biology and medicine 20040701

Title: Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride.

Journal: Microbiological research 20030101

Title: A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Journal: British journal of clinical pharmacology 19800901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 15687-41-9
Tags:15687-41-9 Molecular Formula|15687-41-9 MDL|15687-41-9 SMILES|15687-41-9 Oxyfedrine
Catalog No.: AA01E2BI
15687-41-9,MFCD00869256
15687-41-9 | Oxyfedrine
Pack Size: 5mg
Purity:
3 weeks
$580.00 $406.00
Pack Size: 50mg
Purity:
3 weeks
$3,359.00 $2,351.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01E2BI
Chemical Name: Oxyfedrine
CAS Number: 15687-41-9
Molecular Formula: C19H23NO3
Molecular Weight: 313.3908
MDL Number: MFCD00869256
SMILES: COc1cccc(c1)C(=O)CCN[C@H]([C@@H](c1ccccc1)O)C
Properties
Complexity: 355  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 8  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.4  
Literature fold

Title: Physiological changes induced by chromium stress in plants: an overview.

Journal: Protoplasma20120701

Title: In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains.

Journal: Biological & pharmaceutical bulletin20050401

Title: Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis.

Journal: Bulletin of experimental biology and medicine20041001

Title: Efficiency of refracterin in patients with chronic cardiac insufficiency caused by coronary heart disease.

Journal: Bulletin of experimental biology and medicine20040701

Title: Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride.

Journal: Microbiological research20030101

Title: A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.

Journal: British journal of clinical pharmacology19800901

Building Blocks More >
173070-32-1
173070-32-1
6-Hydroxy-N-demethyldimethidene
AA01E2OK
1936422-33-1
1936422-33-1
GNE-781
AA01E3HN | MFCD31693834
27934-74-3
27934-74-3
cis-1-Chloro-1,5-hexadiene
AA01E3XR
459168-97-9
459168-97-9
MJN228
AA01E4FR
679839-66-8
679839-66-8
BMS193885
AA01E4YN
877052-79-4
877052-79-4
GPBAR-A
AA01E5JR | MFCD27937760
949091-68-3
949091-68-3
Fluoroethyl-PE2I
AA01E5Y0
1184389-53-4
1184389-53-4
[4-(2,2-difluoroethoxy)phenyl]methanol
AA01E6JA | MFCD12768635
35237-29-7
35237-29-7
3-benzylpentanoic acid
AA01E6Y3 | MFCD23160944
2165325-42-6
2165325-42-6
VU 6010608 - Bio-X
AA01E72C | MFCD31693846
Submit
© 2017 AA BLOCKS, INC. All rights reserved.